PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers

被引:29
作者
Colombo, Claudio [1 ]
Morosi, Lavinia [2 ]
Bello, Ezia [2 ]
Ferrari, Raffaele [2 ]
Licandro, Simonetta Andrea [2 ]
Lupi, Monica [2 ]
Ubezio, Paolo [2 ]
Morbidelli, Massimo [3 ]
Zucchetti, Massimo [2 ]
D'Incalci, Maurizio [2 ]
Moscatelli, Davide [1 ]
Frapolli, Roberta [2 ]
机构
[1] Politecn Milan, Dept Chem Mat & Chem Engn, I-20131 Milan, Italy
[2] Ist Ric Farmacol Mario Negri, IRCCS, Dept Oncol, I-20156 Milan, Italy
[3] ETH, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland
关键词
Paclitaxel; Cremophor; Breast Cancer; Nanoparticles; Drug Delivery; Emulsion Polymerization; PLGA-BASED NANOPARTICLES; FREE-RADICAL POLYMERIZATION; SPINAL-CORD-INJURY; DRUG-DELIVERY; CLINICAL TRANSLATION; IN-VITRO; FORMULATION; MICROGLIA/MACROPHAGES; NANOMEDICINES;
D O I
10.1021/acs.molpharmaceut.5b00383
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Polymer nanopartides (NPs) represent a promising way to deliver poorly water-soluble anticancer drugs without the use of unwanted excipients, whose presence can be the cause of severe side effects. In this work, a Cremophor-free formulation for paditaxel (PTX) has been developed by employing PEGylated polymer nanopartides (NPs) as drug delivery carriers based on modified poly(e-caprolactone) macromonomers and synthesized through free radical emulsion polymerization. Paclitaxel was loaded in the NPs in a postsynthesis process which allowed to obtain a drug concentration suitable for in vivo use. In vivo experiments on drug biodistribution and therapeutic efficacy show comparable behavior between the NPs and the Cremophor formulation, also showing good tolerability of the new formulation proposed.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 29 条
[1]   PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect [J].
Acharya, Sarbari ;
Sahoo, Sanjeeb K. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :170-183
[2]  
Adams J D, 1993, J Natl Cancer Inst Monogr, P141
[3]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[4]   Recent advances in stealth coating of nanoparticle drug delivery systems [J].
Amoozgar, Zohreh ;
Yeo, Yoon .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2012, 4 (02) :219-233
[5]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[6]   Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (01) :67-75
[7]   The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma [J].
Cesca, Marta ;
Frapolli, Roberta ;
Berndt, Alexander ;
Scarlato, Valentina ;
Richter, Petra ;
Kosmehl, Hartwig ;
D'Incalci, Maurizio ;
Ryan, Anderson J. ;
Giavazzi, Raffaella .
NEOPLASIA, 2009, 11 (11) :1155-U59
[8]   Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery [J].
Cheng, Jianjun ;
Teply, Benjamin A. ;
Sherifi, Ines ;
Sung, Josephine ;
Luther, Gaurav ;
Gu, Frank X. ;
Levy-Nissenbaum, Etgar ;
Radovic-Moreno, Aleksandar F. ;
Langer, Robert ;
Farokhzad, Omid C. .
BIOMATERIALS, 2007, 28 (05) :869-876
[9]   PLGA-based nanoparticles: An overview of biomedical applications [J].
Danhier, Fabienne ;
Ansorena, Eduardo ;
Silva, Joana M. ;
Coco, Regis ;
Le Breton, Aude ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) :505-522
[10]   Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation [J].
Danhier, Fabienne ;
Lecouturier, Nathalie ;
Vroman, Benoit ;
Jerome, Christine ;
Marchand-Brynaert, Jacqueline ;
Feron, Olivier ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2009, 133 (01) :11-17